INTRODUCTION
The reactive superoxide radical anion, Oz, is a product of the oxygen metabolic cycle/1/. The radical anion is a highly reactive toxic species in many biological systems. Superoxide dismutase (SOD) catalyses Oz dismutation very efficiently and it serves as an important means of defense against oxygen toxicity. It has been discovered /2/ that the superoxide dismutase enzymes catalyze disproportionation of the toxic superoxide ions into molecular oxygen and HzOz (Eq. 1).
2Oz + 2H + SOD Oz + HzO_ () described/3, 8/. However, some Fe/7, 9, 10/and Mn/7, 9, 11/SOD mimics have been reported, and some of them show a marked SOD activity and seem to keep it in living cells/10, 11/. From all these results on native SODs or low molecular weight SOD mimics, it seems that the presence of coordination sites belonging to nitrogen heteroaromatic rings such as imidazoles or pyridines is important to have high SOD activity that is not affected by biological chelators/3, 10/. The problem to solve when searching for SOD-like complexes is to find a balance between a sufficient stability necessary to survive in vivo conditions and a certain flexibility that allows the change of metal coordination occuring during the catalytic process. Apart from the use of various metalloporphyrins/3/, only a few mono-/12/ and bitopie (13) macrocyclic Cu (II) complexes have been investigated as potential SOD-like derivatives, but as aeyelie Cu (II) complexes, they do not resist biological chelators. Recently, two Mn (II) macrocyclic complexes have been shown to exhibit catalytic SOD activity maintained in vivo conditions (13) . Many research groups have been pursuing the possibility of developing such "synzymes" (synthetic enzymes) as an approach to managing various types of diseases. Tremendous progress has been made in this area in recent years, both in defining a role for such a synthetic enzyme as a human pharmacological agent by utilizing a number of animal models for disease, and in progressing toward development of actual drug candidates. The following review briefly introduces the chemistry of the SOD enzymes, surveys recent advances in the synthesis of low molecular weight SOD mimics, and attempts to introduce some of the issues involved with the testing for SOD activity and the chemical design constraints one must satisfy in order to synthesize a highly active enzyme mimic which can function as a human pharmaceutical agent. In particular, emphasis will be made in this review on considerations of development of functional models for a SOD for the metal complexes reported to possess SOD synzyme activity and recent developments in the chemistry of SOD which may have implications for these areas. 
IO MECHANISTIC ASPECTS
Some factors were suggested which may discriminate among the dismutation features of the copper (II) complexes in vitro, and these may include: First a fast exchange of molecules axially linked to the center and a limited steric hindrance to the approach of the superoxide anion are considered essential requirements for the successful binding of the 02 radical/80/. Second the flexibility of the copper (ll) arrangement, which facilitates the interaction of the 02" radical, followed by the rapid electron transfer reaction which results in reduction to copper (ll)-O2" species /32/. Third the favorable response of rt-electrons of the coordinated ligands in stabilizing the Cu(tl)-O2" interaction/7/.
The control of the free radical flux derived from, oxygen is jeopardized in many circumstances in which superoxide (SO) anion production is excessive. This overproduction of SO can overwhelm the body's ability to catalytically dismute superoxide and reduce or eliminate the radical burden. This deleterious oxygenderived free radical has been demonstrated to be a mediator of reperfusion diseases, such as those following acute myocardial infarct or stroke, and shown to be associated with development and continuation of inflammatory processes, involved in diseases such as arthritis, and to play a major role in the initiation of neurological disorders such as Parkinson's disease/81/. Given the high reactivity of the superoxide radical, however, it was hypothesized that Cu, Zn-SOD might also associate with the membrane surfaces of mitochondria and peroxisomes, both of which generate substantial amounts of this radical. To test this hypothesis the subcellular localization of Cu, Zn-SOD was examined in rat brain and liver as well as in cultured human fibroblasts with the use of antibodies specific for Cu, Zn-SOD, Mn-SOD. This test provided direct evidence that Cu, Zn-SOD is associated with both mitochondria and peroxisomes in the brain, liver, and fibroblasts/82/. Higher organisms produce superoxide anion as an occasional byproduct during the oneelectron reduction of dioxygen; this occurs in respiration and photosynthesis. Also, in animals, macrophases generate superoxide as part of the immune response. Organisms must therefore have ways to regulate superoxide concentrations since excess amounts can inactivate enzymes containing iron-sulfur clusters and can lead to the formation of highly oxidizing species damaging to other cellular constituents/83/. Recently, the three-dimensional structure of Cu, Zn-SOD from photobacterium leiognathi has been reported and interesting differences with respect to the eukaryotic SODs have been described concerning the dimer interface region and the assembly of the electrostatic loop forming the active site/84/. This enzyme catalyses a very rapid two-step dismutation of superoxide to dioxygen and hydrogen peroxide through an alternate reduction and oxidation of the active-site copper ion/85/. 
